Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Teachey

Showing results (11-20 of 214) with videos related to

Pageof 22
Sort By:
Blood|November 19, 2019
How I treat newly diagnosed T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in childrenDavid T Teachey, David O'Connor
Expert Review of Clinical Immunology|February 28, 2020
Harnessing immunotherapy for pediatric T-cell malignanciesCaroline Diorio, David T Teachey
Blood|January 19, 2023
TORing the impact of sirolimus on immune healthKandace Gollomp, David T Teachey
Blood|October 10, 2024
A T-ALL order: a new risk classifier for T-ALLHaley Newman, David T Teachey
Blood|March 2, 2023
PI3king apart a rare disease with targeted therapyHaley Newman, David T Teachey
Hematology. American Society of Hematology. Education Program|December 5, 2025
Emerging genomic biomarkers in diagnosis and classification of T-cell acute lymphoblastic leukemiaJason Xu, David T Teachey
Therapeutics and Clinical Risk Management|August 18, 2020
Spotlight on Tocilizumab in the Treatment of CAR-T-Cell-Induced Cytokine Release Syndrome: Clinical Evidence to DateStephanie Si, David T Teachey
Blood|July 7, 2022
Please eat me! Targeting CD47 and CD38 in T-ALLCaroline Diorio, David T Teachey
International Journal of Molecular Sciences|August 12, 2022
A Bright Horizon: Immunotherapy for Pediatric T-Cell MalignanciesHaley Newman, David T Teachey
British Journal of Haematology|July 2, 2013
Predicting relapse risk in childhood acute lymphoblastic leukaemiaDavid T Teachey, Stephen P Hunger
Pageof 22

Showing results (11-20 of 214) with videos related to

Sort By:
Pageof 22
Blood|November 19, 2019
How I treat newly diagnosed T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in childrenDavid T Teachey, David O'Connor
Expert Review of Clinical Immunology|February 28, 2020
Harnessing immunotherapy for pediatric T-cell malignanciesCaroline Diorio, David T Teachey
Blood|January 19, 2023
TORing the impact of sirolimus on immune healthKandace Gollomp, David T Teachey
Blood|October 10, 2024
A T-ALL order: a new risk classifier for T-ALLHaley Newman, David T Teachey
Blood|March 2, 2023
PI3king apart a rare disease with targeted therapyHaley Newman, David T Teachey
Hematology. American Society of Hematology. Education Program|December 5, 2025
Emerging genomic biomarkers in diagnosis and classification of T-cell acute lymphoblastic leukemiaJason Xu, David T Teachey
Therapeutics and Clinical Risk Management|August 18, 2020
Spotlight on Tocilizumab in the Treatment of CAR-T-Cell-Induced Cytokine Release Syndrome: Clinical Evidence to DateStephanie Si, David T Teachey
Blood|July 7, 2022
Please eat me! Targeting CD47 and CD38 in T-ALLCaroline Diorio, David T Teachey
International Journal of Molecular Sciences|August 12, 2022
A Bright Horizon: Immunotherapy for Pediatric T-Cell MalignanciesHaley Newman, David T Teachey
British Journal of Haematology|July 2, 2013
Predicting relapse risk in childhood acute lymphoblastic leukaemiaDavid T Teachey, Stephen P Hunger
Pageof 22